Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Displaying 2295 questions Show Answers
To ask the Scottish Government whether it will compel doctors and consultants to report adverse incidents arising from transvaginal mesh implants.
To ask the Scottish Government what alternative treatments there are to removing transvaginal mesh implants for (a) pelvic organ prolapse and (b) stress urinary incontinence.
To ask the Scottish Government, in light of the Scottish Public Services Ombudsman's ruling in 2009 on a patient given a transvaginal mesh implant without proper consent, what steps it has taken to ensure that people have been given enough information to enable them to give informed consent.
To ask the Scottish Government how many adverse reports it has received of women who received transvaginal mesh implants having been affected by other ailments as a consequence.
To ask the Scottish Government what instructions it gave to NHS boards on the use of transvaginal mesh implants following the ruling by the Scottish Public Sector Ombudsman in 2009 relating to consent.
To ask the Scottish Government whether current procedures to remove transvaginal mesh implants are resulting in patients having to undergo multiple operations.
To ask the Scottish Government what recent discussions it has had with manufacturers of transvaginal mesh implants regarding (a) the suspension of their use and (b) concerns about their impact on women's health.
To ask the Scottish Government what the cost is of each procedure to remove or partially remove a transvaginal mesh implant.
To ask the Scottish Government what consideration it has given to using ultrasound as a treatment in the removal of transvaginal mesh implants.
To ask the Scottish Government what recent discussions it has had with the Medical and Healthcare Products Regulatory Agency in relation to (a) the safety of using and (b) suspending the use of transvaginal mesh implants in treating pelvic organ prolapse and stress urinary incontinence.